SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036360
Filing Date
2020-06-12
Accepted
2020-06-12 17:32:59
Documents
1
Period of Report
2020-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 48668
  Complete submission text file 0001209191-20-036360.txt   50017
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 TENTH AVENUE SUITE 200 NASHVILLE TN 37203
Business Address
Galante Joseph C (Reporting) CIK: 0001632384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 20961222